文献速递胸部肿瘤

体重指数对非小细胞肺癌手术切除后总生存期的影响

The Influence of Body Mass Index on Overall Survival Following Surgical Resection of Non-Small Cell Lung Cancer.
PubMed 文献 · J Thorac Oncol · 2017-05-25

该回顾性单中心研究纳入1935例在M. D. Anderson癌症中心(2000-2014年)接受手术切除的非小细胞肺癌患者,评估体重指数(BMI)对长期总生存期(OS)的影响。多因素分析显示BMI仍是生存的独立预测因素(p=0.02),倾向性匹配分析显示BMI≥30 kg/m2者OS显著优于BMI 25 kg/m2者(p=0.003)。结论认为在控制疾病分期等因素后,较高BMI与术后OS改善相关,需进一步研究阐明其确切关系。

要点

  • 多因素分析显示BMI是NSCLC术后生存的独立预测因素(p=0.02)。
  • 倾向性匹配分析中BMI≥30 kg/m2者OS显著优于BMI 25 kg/m2者(p=0.003)。
  • 病态肥胖(BMI≥35)较其他BMI组仅呈更好结局趋势,与健康体重组比较p=0.37。

核心结论

  • 在这项大型回顾性单中心系列中,控制疾病分期和其他变量后,较高BMI与NSCLC手术切除后OS改善相关。
  • 需进一步研究以阐明BMI与治疗结局之间的确切关系。

研究设计与样本

  • 回顾性单中心系列研究,纳入2000-2014年在M. D. Anderson癌症中心接受肺癌手术切除的1935例患者。
  • 研究变量包括患者相关和治疗相关特征,采用单因素和多因素Cox回归分析识别与OS相关的变量,并进行倾向性匹配分析。

主要发现

  • 单因素分析中,改善生存的显著预测因素包括较高BMI、病理肿瘤分期(I期 vs II、III或IV期)、手术方式(肺叶切除/全肺切除 vs 楔形切除/肺段切除)、较年轻年龄、女性、腺癌组织学亚型(vs 鳞状)(均p<0.05)。
  • 病态肥胖患者(BMI≥35)较肥胖(BMI≥30且<35 kg/m2)呈更好结局趋势(p=0.05,HR=0.727),较超重(BMI≥25且<30 kg/m2)p=0.13(HR=0.848),较健康体重(BMI<25 kg/m2)p=0.37(HR=0.926),健康体重组HR=1。
  • 多因素分析中BMI仍是生存的独立预测因素(p=0.02)。
  • 倾向性匹配分析显示BMI≥30 kg/m2患者较BMI 25 kg/m2患者OS显著更优(p=0.003)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文自述为回顾性、单中心系列研究。
  • 原文结论指出需进一步研究以阐明BMI与治疗结局之间的确切关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Population studies suggest that high body mass index (BMI) correlates with a reduced risk for death from lung cancer. The aim of our study was to evaluate definitively the influence of BMI on long-term overall survival (OS) in surgical patients with NSCLC. METHODS: The study population consisted of 1935 patients who underwent surgical resection for lung cancer at M. D. Anderson Cancer Center (2000-2014). Study variables included both patient- and treatment-related characteristics. Univariate and multivariate Cox regression analyses were performed to identify variables associated with OS. RESULTS: On univariate analysis, significant predictors of improved survival were higher BMI, pathologic tumor stage (stage I versus stage II, III, or IV), type of surgical procedure (lobectomy/pneumonectomy versus wedge resection/segmentectomy), younger age, female sex, and adenocarcinoma histologic subtype (versus squamous) (all p < 0.05). Morbidly obese patients (BMI ≥ 35) demonstrated a trend toward better outcomes than those classified as obese (BMI ≥30 and <35 kg/m2) (p = 0.05), overweight (BMI ≥ 25 and <30 kg/m2) (p = 0.13), or healthy weight (BMI <25 kg/m2) (p = 0.37) (hazard ratio = 0.727, 0.848, 0.926, and 1, respectively). On multivariate analysis, BMI remained an independent predictor of survival (p = 0.02). Propensity matching analysis demonstrated significantly better OS (p = 0.003) in patients with a BMI of 30 kg/m2 or higher as compared with a BMI of 25 kg/m2. CONCLUSIONS: In this large, retrospective, single-center series, after control for disease stage and other variables, higher BMI was associated with improved OS after surgical resection of NSCLC. Further studies are necessary to elucidate the precise relationship between BMI and treatment outcomes.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Sepesi B, Gold KA, Correa AM, et al. The Influence of Body Mass Index on Overall Survival Following Surgical Resection of Non-Small Cell Lung Cancer. J Thorac Oncol. 2017. PMID: 28552766. doi:10.1016/j.jtho.2017.05.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。